130 - QMSR Changes to Traceability/Reporting, Independent Reviewer & Risk Management, Learning New Regulations and MDSAP with Aaron Snyder

Let's Combinate - Combining Drugs and Devices

Conteúdo fornecido por Subhi Saadeh. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por Subhi Saadeh ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.

7M ago 32:25

MP3•Home de episódios

On this episode I was joined by Aaron Snyder, VP of Quality Assurance at Allotex. Aaron discusses:

00:58 Exploring the Impact of QMSR on Medical Device Companies

02:19 UDI Regulations

05:18 Understanding the FDA's Approach to QMSR and Compliance

18:02 The FDA's Inspection Techniques and the Future of QMSR

31:55 Where to Find Aaron and Closing Thoughts

Aaron Snyder is a quality management systems expert and is the VP of QA at Allotex. Prior to joining Allotex, Aaron served in roles at Fresenius Kabi, Molnlycke, Waters Corporation, Covidien, Cardinal Health, and General Electric. He has worked with a wide range of pharmaceuticals, medical devices and combination products. Aaron is a member of the AAMI Faculty and teaches several courses focused on various QMS topics. Aaron is also and avid content creator and dissects, presents and teaches on QMS and cGMP’s topics on his YouTube channel: Quality Systems Explained.

161 episódios

#Science #Biology #Subhi Saadeh